Next Article in Journal
Volumetric Absorptive Microsampling of Saliva for Pharmacokinetic Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Pediatric Renal Transplant Recipients: Bioanalytical Method Validation and Clinical Feasibility Evaluation
Previous Article in Journal
Advancing Internal Dosimetry in Personalized Nuclear Medicine: Toward Optimized Radiopharmaceutical Use in Clinical Practice
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Bedeschi et al. Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies. Pharmaceuticals 2025, 18, 385

1
Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy
2
Radiation Oncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2025, 18(11), 1742; https://doi.org/10.3390/ph18111742
Submission received: 29 September 2025 / Accepted: 11 October 2025 / Published: 17 November 2025
(This article belongs to the Section Pharmacology)

References

In the original publication [1], the reference 22 was retracted and it has been replaced the new reference as below:
22.
Miller, T.E.; El Farran, C.A.; Couturier, C.P.; Chen, Z.; D’Antonio, J.P.; Verga, J.; Villanueva, M.A.; Gonzalez Castro, L.N.; Tong, Y.E.; Saadi, T.A.; et al. Programs, origins and immunomodulatory functions of myeloid cells in glioma. Nature 2025, 640, 1072–1082. https://doi.org/10.1038/s41586-025-08633-8.
This correction was approved by the Academic Editor, and the authors state that their scientific conclusions remain unaffected. The original publication has also been updated.

Reference

  1. Bedeschi, M.; Cavassi, E.; Romeo, A.; Tesei, A. Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies. Pharmaceuticals 2025, 18, 385. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bedeschi, M.; Cavassi, E.; Romeo, A.; Tesei, A. Correction: Bedeschi et al. Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies. Pharmaceuticals 2025, 18, 385. Pharmaceuticals 2025, 18, 1742. https://doi.org/10.3390/ph18111742

AMA Style

Bedeschi M, Cavassi E, Romeo A, Tesei A. Correction: Bedeschi et al. Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies. Pharmaceuticals 2025, 18, 385. Pharmaceuticals. 2025; 18(11):1742. https://doi.org/10.3390/ph18111742

Chicago/Turabian Style

Bedeschi, Martina, Elena Cavassi, Antonino Romeo, and Anna Tesei. 2025. "Correction: Bedeschi et al. Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies. Pharmaceuticals 2025, 18, 385" Pharmaceuticals 18, no. 11: 1742. https://doi.org/10.3390/ph18111742

APA Style

Bedeschi, M., Cavassi, E., Romeo, A., & Tesei, A. (2025). Correction: Bedeschi et al. Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies. Pharmaceuticals 2025, 18, 385. Pharmaceuticals, 18(11), 1742. https://doi.org/10.3390/ph18111742

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop